Summary

KEY FINDINGS
The Asia-Pacific magnetic resonance imaging (MRI) systems market size is valued at $2,087.81 million as of 2026 and is expected to reach $3,686.90 million by 2034, progressing with a CAGR of 7.37% during the forecast years, 2026-2034.

MARKET INSIGHTS
Rapid economic development combined with expanding healthcare infrastructure positions Asia-Pacific as the fastest-growing MRI systems market globally. Government healthcare reforms across emerging economies prioritize diagnostic imaging accessibility through substantial capital investments. Rising middle-class populations increasingly demand quality healthcare services comparable to developed nations.
Moreover, aging demographics throughout the region drive escalating chronic disease prevalence, requiring advanced diagnostic capabilities. Healthcare expenditure per capita continues rising steadily as economic prosperity expands across urban and rural communities. Additionally, medical tourism initiatives position regional hospitals as diagnostic hubs, attracting international patients seeking cost-effective, high-quality imaging services. Consequently, hospitals and diagnostic centers modernize equipment fleets rapidly to capture growing procedure volumes efficiently.

REGIONAL ANALYSIS
The Asia-Pacific magnetic resonance imaging (MRI) systems market growth assessment includes the analysis of China, Japan, India, South Korea, Indonesia, Vietnam, Thailand, Australia & New Zealand, and Rest of Asia-Pacific.
China represents the fastest-expanding magnetic resonance imaging systems market within Asia-Pacific currently, driven by comprehensive healthcare reforms and infrastructure development. The National Medical Products Administration (NMPA) implements streamlined approval processes for high-end medical devices, including advanced MRI systems.
Recent regulatory initiatives announced in 2025 accelerate review timelines for innovative imaging technologies through priority pathways. Moreover, China's massive population base creates unprecedented demand for diagnostic imaging services across all clinical specialties. Domestic manufacturers, including Mindray and United Imaging, compete aggressively against established international brands through competitive pricing strategies.
Government policies actively encourage the localization of medical device manufacturing through favorable procurement preferences. Furthermore, healthcare insurance coverage expansion removes financial barriers, enabling broader patient access to advanced imaging procedures. Telemedicine networks connect rural facilities with urban radiologist expertise through sophisticated cloud-based platforms. Additionally, China's Belt and Road Initiative extends healthcare infrastructure development beyond national borders, creating export opportunities for domestic manufacturers.
India demonstrates exceptional growth potential within the Asia-Pacific magnetic resonance imaging systems market despite infrastructure challenges. The Central Drugs Standard Control Organisation (CDSCO) regulates medical device imports and manufacturing under the Medical Devices Rules, 2017. Healthcare facilities face acute shortages of advanced diagnostic imaging equipment relative to population size. However, private hospital chains and diagnostic imaging centers invest aggressively in MRI systems to serve growing middle-class demand.
Moreover, government initiatives promoting universal healthcare coverage drive public hospital infrastructure modernization gradually. Medical device manufacturers must navigate complex regulatory requirements, including home country approval verification and reference country authorization. Furthermore, refurbished MRI equipment imports face regulatory scrutiny amid concerns about safety standards and domestic manufacturing protection. Tier-II and Tier-III cities present significant untapped market opportunities where advanced imaging remains largely unavailable. Additionally, India's skilled radiologist workforce, combined with English proficiency, positions the country as a teleradiology service hub globally.
Japan maintains a sophisticated magnetic resonance imaging systems market characterized by high equipment density and advanced technology adoption. The Pharmaceuticals and Medical Devices Agency (PMDA) enforces rigorous quality standards through comprehensive review processes for medical devices. MRI scanners are classified as Class II devices requiring moderate-risk oversight, including third-party certification by registered bodies.
Japanese healthcare facilities demonstrate a strong preference for domestically manufactured equipment from established brands like Canon Medical Systems. Moreover, Japan's aging population drives sustained demand for neurological and oncological diagnostic imaging services. Universal healthcare coverage ensures patient access to advanced imaging without significant financial barriers. Furthermore,
On the other hand, Japanese medical device regulations require Japanese-language documentation and often mandate local clinical data for novel technologies. The PMDA has recently accelerated approval timelines for software as medical devices, including AI-powered MRI applications. Additionally, Japan's participation in international regulatory forums like IMDRF facilitates global harmonization efforts.

SEGMENTATION ANALYSIS
The Asia-Pacific magnetic resonance imaging (MRI) systems market is segmented into architecture, field type, and application. The application segment is further categorized into brain and neurology MRI system, spine and musculoskeletal MRI system, pelvic and abdominal MRI system, oncology MRI system, vascular MRI system, cardiology MRI system, pediatric MRI system, gastroenterology MRI system, and other applications.
Brain and neurology MRI systems command substantial market share within the Asia-Pacific region due to rising neurological disease prevalence. Stroke, dementia, epilepsy, and brain tumors create significant diagnostic imaging demand across all age demographics. These specialized MRI applications require high-resolution imaging capabilities that reveal subtle anatomical and functional brain abnormalities.
Healthcare facilities prioritize brain imaging protocols when selecting MRI equipment, given their clinical importance and utilization frequency. Moreover, neurological disorders represent the leading causes of disability and mortality throughout the Asia-Pacific populations. Advanced sequences, including diffusion-weighted imaging, susceptibility-weighted imaging, and functional MRI, enhance diagnostic precision for complex neurological conditions.
Furthermore, brain and neurology applications drive demand for high-field and ultra-high-field MRI systems, offering superior image quality. Research institutions throughout the region conduct groundbreaking neuroscience investigations utilizing specialized brain imaging capabilities. Additionally, telemedicine networks enable expert neurologist consultations based on remotely transmitted MRI examinations. Consequently, brain and neurology MRI systems represent strategic investments for facilities seeking comprehensive diagnostic capabilities.

COMPETITIVE INSIGHTS
Some of the top players operating in the Asia-Pacific magnetic resonance imaging (MRI) systems market include Siemens Healthineers, Canon Medical Systems Corp, Philips Healthcare, Mindray Medical International Limited, etc.
Mindray Medical International Limited operates as a leading Chinese medical equipment manufacturer headquartered in Shenzhen, specializing in patient monitoring, in vitro diagnostics, and medical imaging systems. The company manufactures cost-effective MRI solutions targeted at emerging market healthcare facilities requiring affordable yet reliable diagnostic capabilities.
Mindray's MRI product line emphasizes ease of operation, compact footprints, and simplified service requirements suitable for resource-constrained environments. Their systems incorporate locally developed technologies, reducing dependence on imported components and enabling competitive pricing strategies.
Moreover, Mindray maintains extensive distribution networks throughout China and is expanding its international presence across Southeast Asia, Africa, and Latin America. The company benefits from strong government support for domestic medical device manufacturing under "Made in China" initiatives.

COMPANY PROFILES
1. ANALOGIC CORPORATION
2. AURORA IMAGING TECHNOLOGY INC
3. CANON MEDICAL SYSTEMS CORP
4. CARESTREAM HEALTH INC
5. ESAOTE SPA
6. FONARCORPORATION
7. FUJIFILM HOLDINGS CORPORATION
8. GE HEALTHCARE
9. HOLOGIC INC
10. KONICA MINOLTA
11. MEDTRONIC PLC
12. MINDRAY MEDICAL INTERNATIONAL LIMITED
13. PHILIPS HEALTHCARE
14. SHIMADZU CORP
15. SIEMENS HEALTHINEERS

ページTOPに戻る

Table of Contents

FORECAST 2026-2034
TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. THE MRI SYSTEMS MARKET IS EXPERIENCING STRONG GROWTH DRIVEN BY EXPANDING DEMAND FOR ADVANCED DIAGNOSTIC IMAGING CAPABILITIES IN HOSPITALS AND DIAGNOSTIC CENTERS
2.5.2. THE MARKET IS SUPPORTED BY BROAD ADOPTION OF HIGH‑FIELD AND ULTRA‑LOW‑FIELD SYSTEMS
2.5.3. ASIA‑PACIFIC IS FORECAST TO EXPAND AT THE FASTEST RATE DUE TO INCREASING HEALTHCARE INVESTMENTS
2.5.4. PORTABLE AND COMPACT MRI SYSTEMS ARE OPENING NEW ACCESS POINTS IN OUTPATIENT, REMOTE, AND POINT‑OF‑CARE SETTINGS, SHAPING MARKET EXPANSION BEYOND TRADITIONAL HOSPITAL ENVIRONMENTS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC AND NEUROLOGICAL DISEASES IS ACCELERATING THE NEED FOR SOPHISTICATED IMAGING TECHNIQUES THAT MRI TECHNOLOGY PROVIDES
3.1.2. TECHNOLOGICAL ADVANCEMENTS INCLUDING AI INTEGRATION, HIGH‑RESOLUTION IMAGING, AND FASTER SCANNING CAPABILITIES ARE ENCOURAGING ADOPTION ACROSS HEALTHCARE FACILITIES
3.1.3. INCREASING HEALTHCARE EXPENDITURE AND INFRASTRUCTURE DEVELOPMENT IN EMERGING ECONOMIES IS BOOSTING MARKET PENETRATION AND CAPITAL EQUIPMENT PURCHASES
3.1.4. EXPANDING OUTPATIENT SERVICES AND SHIFT TOWARD NON‑INVASIVE DIAGNOSTICS ARE MAKING MRI SYSTEMS MORE FREQUENTLY UTILIZED ACROSS CARE SETTINGS
3.2. KEY RESTRAINTS
3.2.1. HIGH ACQUISITION, INSTALLATION, AND MAINTENANCE COSTS OF MRI SYSTEMS REMAIN A SIGNIFICANT BARRIER FOR SMALLER FACILITIES AND LOW‑RESOURCE REGIONS
3.2.2. LIMITED ACCESS IN RURAL AND UNDERDEVELOPED AREAS PERSISTENTLY RESTRICTS BROADER MARKET REACH AND EQUITABLE CARE DELIVERY
3.2.3. SHORTAGE OF SKILLED PERSONNEL AND RADIOLOGISTS FOR OPERATING ADVANCED MRI MACHINES HINDERS OPTIMAL UTILIZATION AND SCANNING CAPACITY
3.2.4. STRINGENT REGULATORY REQUIREMENTS AND COMPLEX APPROVAL PROCESSES CAN DELAY MARKET ENTRY FOR NEW MRI TECHNOLOGIES
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MRI SYSTEMS IS ENHANCING IMAGE QUALITY, WORKFLOW EFFICIENCY, AND DIAGNOSTIC ACCURACY
4.1.2. GROWTH IN PORTABLE AND LOW‑FIELD MRI TECHNOLOGIES IS EXTENDING DIAGNOSTIC CAPABILITY TO REMOTE, OUTPATIENT, AND POINT‑OF‑CARE SETTINGS
4.1.3. INCREASING FOCUS ON PATIENT COMFORT THROUGH OPEN, LOW‑NOISE, AND SHORTER SCAN MRI DESIGNS IS INFLUENCING PURCHASE DECISIONS
4.1.4. SHIFT TOWARD AMBULATORY AND OUTSIDE HOSPITAL DIAGNOSTIC SERVICES IS EXPANDING MRI UTILIZATION BEYOND TRADITIONAL INPATIENT SETTINGS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MAGNETIC COIL MANUFACTURING
4.6.2. MAGNET AND COMPONENT SUPPLY
4.6.3. MRI SYSTEM ASSEMBLY
4.6.4. SOFTWARE & AI INTEGRATION
4.6.5. DISTRIBUTION & LOGISTICS
4.6.6. INSTALLATION & VALIDATION
4.6.7. TRAINING & MAINTENANCE SERVICES
4.6.8. AFTERMARKET SUPPORT
4.7. KEY BUYING CRITERIA
4.7.1. IMAGE QUALITY & RESOLUTION
4.7.2. TOTAL COST OF OWNERSHIP
4.7.3. PATIENT COMFORT FEATURES
4.7.4. SERVICE & TECHNICAL SUPPORT
4.8. REGULATORY FRAMEWORK
5. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY ARCHITECTURE
5.1. CLOSED MRI SYSTEMS
5.1.1. STANDARD BORE MRI SYSTEMS
5.1.2. WIDE BORE MRI SYSTEMS
5.2. OPEN MRI SYSTEMS
6. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY FIELD TYPE
6.1. HIGH FIELD SYSTEMS
6.1.1. 1.5T SYSTEM
6.1.2. 3T SYSTEM
6.2. LOW-MID FIELD SYSTEMS
6.3. ULTRA HIGH FIELD SYSTEMS
7. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY APPLICATION
7.1. BRAIN AND NEUROLOGY MRI SYSTEM
7.2. SPINE AND MUSCULOSKELETAL MRI SYSTEM
7.3. PELVIC AND ABDOMINAL MRI SYSTEM
7.4. ONCOLOGY MRI SYSTEM
7.5. VASCULAR MRI SYSTEM
7.6. CARDIOLOGY MRI SYSTEM
7.7. PEDIATRIC MRI SYSTEM
7.8. GASTROENTEROLOGY MRI SYSTEM
7.9. OTHER APPLICATIONS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. ASIA-PACIFIC MARKET DRIVERS
8.1.3. ASIA-PACIFIC MARKET CHALLENGES
8.1.4. KEY PLAYERS IN ASIA-PACIFIC MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.1.1. CHINA MARKET SIZE & OPPORTUNITIES
8.1.5.2. INDIA
8.1.5.2.1. INDIA MARKET SIZE & OPPORTUNITIES
8.1.5.3. JAPAN
8.1.5.3.1. JAPAN MARKET SIZE & OPPORTUNITIES
8.1.5.4. AUSTRALIA & NEW ZEALAND
8.1.5.4.1. AUSTRALIA & NEW ZEALAND MARKET SIZE & OPPORTUNITIES
8.1.5.5. SOUTH KOREA
8.1.5.5.1. SOUTH KOREA MARKET SIZE & OPPORTUNITIES
8.1.5.6. THAILAND
8.1.5.6.1. THAILAND MARKET SIZE & OPPORTUNITIES
8.1.5.7. INDONESIA
8.1.5.7.1. INDONESIA MARKET SIZE & OPPORTUNITIES
8.1.5.8. VIETNAM
8.1.5.8.1. VIETNAM MARKET SIZE & OPPORTUNITIES
8.1.5.9. REST OF ASIA-PACIFIC
8.1.5.9.1. REST OF ASIA-PACIFIC MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ANALOGIC CORPORATION
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCTS
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. AURORA IMAGING TECHNOLOGY INC
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. CANON MEDICAL SYSTEMS CORP
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCTS
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. CARESTREAM HEALTH INC
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. ESAOTE SPA
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCTS
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. FONARCORPORATION
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. FUJIFILM HOLDINGS CORPORATION
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCTS
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. GE HEALTHCARE
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. HOLOGIC INC
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. KONICA MINOLTA
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCTS
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. MEDTRONIC PLC
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. MINDRAY MEDICAL INTERNATIONAL LIMITED
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. PHILIPS HEALTHCARE
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCTS
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. SHIMADZU CORP
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. SIEMENS HEALTHINEERS
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS
9.2.15.3. STRENGTHS & CHALLENGES








LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
TABLE 2: MARKET BY ARCHITECTURE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 3: MARKET BY ARCHITECTURE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 4: MARKET BY CLOSED MRI SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 5: MARKET BY CLOSED MRI SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 6: MARKET BY FIELD TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 7: MARKET BY FIELD TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 8: MARKET BY HIGH FIELD SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 9: MARKET BY HIGH FIELD SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 10: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 14: KEY PLAYERS OPERATING IN THE ASIA-PACIFIC MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY ARCHITECTURE, IN 2025
FIGURE 9: CLOSED MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: SEGMENT GROWTH POTENTIAL, BY CLOSED MRI SYSTEMS, IN 2025
FIGURE 11: STANDARD BORE MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: WIDE BORE MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: OPEN MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: SEGMENT GROWTH POTENTIAL, BY FIELD TYPE, IN 2025
FIGURE 15: HIGH FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: SEGMENT GROWTH POTENTIAL, BY HIGH FIELD SYSTEMS, IN 2025
FIGURE 17: 1.5T SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 18: 3T SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: LOW-MID FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: ULTRA HIGH FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 22: BRAIN AND NEUROLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 23: SPINE AND MUSCULOSKELETAL MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: VASCULAR MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: PELVIC AND ABDOMINAL MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 26: ONCOLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: CARDIOLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: PEDIATRIC MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: GASTROENTEROLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 30: OTHER APPLICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET, COUNTRY OUTLOOK, 2025 & 2034 (IN %)
FIGURE 32: CHINA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: INDIA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 34: JAPAN MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 36: SOUTH KOREA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 37: THAILAND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 38: INDONESIA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 39: VIETNAM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC MARKET SIZE, 2026-2034 (IN $ MILLION)

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
TABLE 2: MARKET BY ARCHITECTURE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 3: MARKET BY ARCHITECTURE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 4: MARKET BY CLOSED MRI SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 5: MARKET BY CLOSED MRI SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 6: MARKET BY FIELD TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 7: MARKET BY FIELD TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 8: MARKET BY HIGH FIELD SYSTEMS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 9: MARKET BY HIGH FIELD SYSTEMS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 10: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 14: KEY PLAYERS OPERATING IN THE ASIA-PACIFIC MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES